Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA

S. Koido, M. Kashiwaba, D. Chen, Sandra J Gendler, D. Kufe, J. Gong

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Dendritic cells (DC) are potent APCs. In this study, murine bone marrow-derived DC were transfected with RNA encoding the MUC1 Ag that is aberrantly overexpressed in human breast and other carcinomas. The MUC1 RNA-transfected DC exhibited cell surface expression of MUC1 and costimulatory molecules. After injection at the base of the tail, the transfected DC were detectable in inguinal lymph nodes by dual immunochemical staining. Vaccination of wild-type mice with MUC1 RNA-transfected DC induced anti-MUC1 immune responses against MUC1-positive MC38/MUC1, but not MUC1-negative, tumor cells. Mice immunized with the transfected DC were protected against challenge with MC38/MUC1 tumor cells. Furthermore, mice with established MC38/MUC1 tumors were eliminated after receiving the vaccination. CTLs isolated from mice immunized with the transfected DC exhibited specific cytolytic activity against MC38/MUC1 tumor cells. In contrast to these findings, there was little if any anti-MUC1 immunity induced with the transfected DC in MUC1 transgenic (MUC1.Tg) mice. However, coadministration of the transfected DC and IL-12 reversed the unresponsiveness to MUC1 Ag in MUC1.Tg mice and induced MUC1-specific immune responses. These findings demonstrate that vaccination of DC transfected with MUC1 RNA and IL-12 reverses tolerance to MUC1 and induces immunity against MUC1-positive tumors.

Original languageEnglish (US)
Pages (from-to)5713-5719
Number of pages7
JournalJournal of Immunology
Volume165
Issue number10
StatePublished - Nov 15 2000
Externally publishedYes

Fingerprint

Dendritic Cells
Immunity
Vaccination
RNA
Neoplasms
Interleukin-12
Groin
Transgenic Mice
Tail
Lymph Nodes
Bone Marrow
Staining and Labeling
Breast Neoplasms
Injections

ASJC Scopus subject areas

  • Immunology

Cite this

Koido, S., Kashiwaba, M., Chen, D., Gendler, S. J., Kufe, D., & Gong, J. (2000). Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. Journal of Immunology, 165(10), 5713-5719.

Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. / Koido, S.; Kashiwaba, M.; Chen, D.; Gendler, Sandra J; Kufe, D.; Gong, J.

In: Journal of Immunology, Vol. 165, No. 10, 15.11.2000, p. 5713-5719.

Research output: Contribution to journalArticle

Koido, S, Kashiwaba, M, Chen, D, Gendler, SJ, Kufe, D & Gong, J 2000, 'Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA', Journal of Immunology, vol. 165, no. 10, pp. 5713-5719.
Koido, S. ; Kashiwaba, M. ; Chen, D. ; Gendler, Sandra J ; Kufe, D. ; Gong, J. / Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. In: Journal of Immunology. 2000 ; Vol. 165, No. 10. pp. 5713-5719.
@article{6854bfb8c90a4d5fb9be0256001fe35f,
title = "Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA",
abstract = "Dendritic cells (DC) are potent APCs. In this study, murine bone marrow-derived DC were transfected with RNA encoding the MUC1 Ag that is aberrantly overexpressed in human breast and other carcinomas. The MUC1 RNA-transfected DC exhibited cell surface expression of MUC1 and costimulatory molecules. After injection at the base of the tail, the transfected DC were detectable in inguinal lymph nodes by dual immunochemical staining. Vaccination of wild-type mice with MUC1 RNA-transfected DC induced anti-MUC1 immune responses against MUC1-positive MC38/MUC1, but not MUC1-negative, tumor cells. Mice immunized with the transfected DC were protected against challenge with MC38/MUC1 tumor cells. Furthermore, mice with established MC38/MUC1 tumors were eliminated after receiving the vaccination. CTLs isolated from mice immunized with the transfected DC exhibited specific cytolytic activity against MC38/MUC1 tumor cells. In contrast to these findings, there was little if any anti-MUC1 immunity induced with the transfected DC in MUC1 transgenic (MUC1.Tg) mice. However, coadministration of the transfected DC and IL-12 reversed the unresponsiveness to MUC1 Ag in MUC1.Tg mice and induced MUC1-specific immune responses. These findings demonstrate that vaccination of DC transfected with MUC1 RNA and IL-12 reverses tolerance to MUC1 and induces immunity against MUC1-positive tumors.",
author = "S. Koido and M. Kashiwaba and D. Chen and Gendler, {Sandra J} and D. Kufe and J. Gong",
year = "2000",
month = "11",
day = "15",
language = "English (US)",
volume = "165",
pages = "5713--5719",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA

AU - Koido, S.

AU - Kashiwaba, M.

AU - Chen, D.

AU - Gendler, Sandra J

AU - Kufe, D.

AU - Gong, J.

PY - 2000/11/15

Y1 - 2000/11/15

N2 - Dendritic cells (DC) are potent APCs. In this study, murine bone marrow-derived DC were transfected with RNA encoding the MUC1 Ag that is aberrantly overexpressed in human breast and other carcinomas. The MUC1 RNA-transfected DC exhibited cell surface expression of MUC1 and costimulatory molecules. After injection at the base of the tail, the transfected DC were detectable in inguinal lymph nodes by dual immunochemical staining. Vaccination of wild-type mice with MUC1 RNA-transfected DC induced anti-MUC1 immune responses against MUC1-positive MC38/MUC1, but not MUC1-negative, tumor cells. Mice immunized with the transfected DC were protected against challenge with MC38/MUC1 tumor cells. Furthermore, mice with established MC38/MUC1 tumors were eliminated after receiving the vaccination. CTLs isolated from mice immunized with the transfected DC exhibited specific cytolytic activity against MC38/MUC1 tumor cells. In contrast to these findings, there was little if any anti-MUC1 immunity induced with the transfected DC in MUC1 transgenic (MUC1.Tg) mice. However, coadministration of the transfected DC and IL-12 reversed the unresponsiveness to MUC1 Ag in MUC1.Tg mice and induced MUC1-specific immune responses. These findings demonstrate that vaccination of DC transfected with MUC1 RNA and IL-12 reverses tolerance to MUC1 and induces immunity against MUC1-positive tumors.

AB - Dendritic cells (DC) are potent APCs. In this study, murine bone marrow-derived DC were transfected with RNA encoding the MUC1 Ag that is aberrantly overexpressed in human breast and other carcinomas. The MUC1 RNA-transfected DC exhibited cell surface expression of MUC1 and costimulatory molecules. After injection at the base of the tail, the transfected DC were detectable in inguinal lymph nodes by dual immunochemical staining. Vaccination of wild-type mice with MUC1 RNA-transfected DC induced anti-MUC1 immune responses against MUC1-positive MC38/MUC1, but not MUC1-negative, tumor cells. Mice immunized with the transfected DC were protected against challenge with MC38/MUC1 tumor cells. Furthermore, mice with established MC38/MUC1 tumors were eliminated after receiving the vaccination. CTLs isolated from mice immunized with the transfected DC exhibited specific cytolytic activity against MC38/MUC1 tumor cells. In contrast to these findings, there was little if any anti-MUC1 immunity induced with the transfected DC in MUC1 transgenic (MUC1.Tg) mice. However, coadministration of the transfected DC and IL-12 reversed the unresponsiveness to MUC1 Ag in MUC1.Tg mice and induced MUC1-specific immune responses. These findings demonstrate that vaccination of DC transfected with MUC1 RNA and IL-12 reverses tolerance to MUC1 and induces immunity against MUC1-positive tumors.

UR - http://www.scopus.com/inward/record.url?scp=0034670002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034670002&partnerID=8YFLogxK

M3 - Article

C2 - 11067929

AN - SCOPUS:0034670002

VL - 165

SP - 5713

EP - 5719

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -